Lung cancer is still one of the most common malignancies with a high global mortality rate with over 2 million cases confirmed by the World Health Organization in 2018. Although there has been ...

A new molecular imaging agent can accurately identify a crucial biomarker found among many different types of cancer. Precise ...

Monotherapy activity with inhaled KB707 provides further evidence of successful repeat administration of HSV-1 based inhaled lung gene delivery and builds on recent clinical data update for CF and AAT ...

From detecting early disease to guiding treatment plans, clinicians are finding ctDNA testing increasingly important.

Over a 45-years span — between 1975 and 2020 — improvements in cancer screenings and prevention strategies have reduced ...

Liam Handley - who had suffered from anxiety for much of his life - went to his GP with chest pains, which his doctor put ...

Cancer survival estimates in Europe highlight notable geographical and economic disparities. Several factors are driving gaps ...

China's homegrown medicines are expected to play a more important role in tumor treatment as domestic researchers and ...

Teos Therapeutics has potential lung cancer treatment despite issues and strong financial position. Read here to know why we ...

Jazz Pharmaceuticals announced that the FDA has approved ZIIHERA® (zanidatamab-hrii) on an accelerated basis for the treatment ...

The FDA granted breakthrough therapy designation to sacituzumab govitecan for patients with ES-SCLC progressing on platinum ...

Bobbi Conner talks with MUSC's Dr. Tucker Marrison about cancer screening recommendations for adults, with an update about ...